CClinicalTrials.gg
CompletedNCT01660503Updated May 4, 2018

Dose Effects of SCF on Calcium Metabolism and GI Microflora in Adolescents

An interventional study of 0 grams SCF and 10 grams SCF in Osteoporosis, sponsored by Purdue University. Completed at 1 site in United States. Open to female participants aged 9 Years to 13 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-05-04.

Sponsored by Purdue University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
9 Years to 13 Years
Sex
Female
01

Study summary

Soluble corn fiber (SCF) has been shown to enhance calcium utilization and bone properties in rats and in adolescent boys and girls.

Read the detailed description

The growing knowledge of non-digestible oligosaccharide (NDO)-related health benefits has led to the identification of other fermentable carbohydrates which may improve bone balance and bone health parameters. One such carbohydrate is the corn derivative, soluble corn fiber (SCF). Already known for its association with improved intestinal health and influence on colonic microflora content, we have been studying the effects of SCF on calcium absorption and bone health. First we found that soluble corn fiber (SCF) greatly enhanced calcium utilization and bone properties in a growing rat model. Results from this study demonstrated that SCF was capable of increasing bone mineral content, density and bone strength parameters in 4-week old, male rats. Our study in adolescent boys and girls showed a 12% increase in calcium absorption after consuming 12 g SCF for 21 days compared to a control period in a crossover design using a controlled feeding metabolic balance approach. Given these profound changes on calcium absorption and in bone, a logical next step is to study a dose-response effect of SCF on calcium absorption, bone turnover, and gut microflora in free-living adolescents.

02

Conditions studied

  • Osteoporosis

Browse trials for

Keywords

  • Calcium absorption
  • Osteoporosis
  • Bone Health
  • Adolescent
03

In context

Osteoporosis

1,640 studies on the registry are indexed under Osteoporosis; 212 are open to participants now.

This study's enrollment of 30 is below the median of 95 across 1,133 interventional studies indexed under Osteoporosis.

Browse Osteoporosis studies →

Lead sponsor

Purdue University is the lead sponsor of 168 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
9 Years to 13 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy adolescent Caucasian girls between the ages of 12-14. This population has been chosen because they exhibit higher risk for osteoporosis later in life.

Exclusion criteria

Exclusion Criteria:

  • Habitual dietary patterns including less than 550 and greater than 1500 mg Ca per day. This represents the 5th and 95th percentile of usual intake of girls 9-13 y in the US.
  • History of smoking, alcohol use, illegal or non-prescription drug use
  • History of disordered calcium or bone metabolism e.g. Paget's disease, hyper or hypo-calcemia
  • History of gastrointestinal diseases (Crohn's, celiac, inflammatory bowel disease)
  • History of diseases that affect kidney or liver function.
  • Body Mass Index (BMI) less than 5th percentile for age or greater than the 90th percentile for age
  • Having a broken bone within the last 6 months.
  • Regular consumption of foods or supplements containing prebiotics or probiotics
  • History of pregnancy or use of contraceptives
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
30 participants (actual)

Study arms

  • Placebo comparator
    No SCF

    Twice daily consumption of snack foods containing no SCF.

    Dietary Supplement: 0 grams SCF

  • Experimental
    10 grams SCF

    Twice daily consumption of snack foods, each containing 5 grams SCF

    Dietary Supplement: 10 grams SCF

  • Experimental
    20 grams SCF

    Twice daily consumption of snack foods, each containing 10 grams SCF

    Dietary Supplement: 20 grams SCF

Interventions

  • Dietary supplement0 grams SCF

    Given in snack foods (muffins and flavored beverage)

  • Dietary supplement10 grams SCF

    Given in snack foods (muffins and flavored beverage)

  • Dietary supplement20 grams SCF

    Given in snack foods (muffins and flavored beverage)

06

What researchers measure

Primary outcomes

  1. Calcium Absorption

    The subject will be asked to consume one snack item in the morning and one snack in the evening for four consecutive weeks. After consuming the SCF product for four weeks the teen will come to Purdue University campus for 3 nights and days (e.g. Thursday noon - Sunday noon). They will reside in university residence hall or hotel near campus. Calcium Absorption testing will be done utilizing 43Ca and 44Ca.

    Time frame: 4 Weeks

Secondary outcomes

  1. GI microbial changes

    Fecal microbial analyses will be performed on a baseline sample collected before each 4 week consumption period to establish basal microbial profiles. Additional analyses will be performed on fecal samples collected during the 3 day clinical visit to compare microbial changes in response to SCF treatments.

    Time frame: 4 weeks

07

Study locations

1 site
  • Purdue University
    West Lafayette, Indiana 47907, United States
08

References and documents

Publications

  • Whisner CM, Martin BR, Nakatsu CH, Story JA, MacDonald-Clarke CJ, McCabe LD, McCabe GP, Weaver CM. Soluble Corn Fiber Increases Calcium Absorption Associated with Shifts in the Gut Microbiome: A Randomized Dose-Response Trial in Free-Living Pubertal Females. J Nutr. 2016 Jul;146(7):1298-306. doi: 10.3945/jn.115.227256. Epub 2016 Jun 8. PubMed 27281813 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 4, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01660503
Lead sponsor
Purdue University
Collaborators
Tate and Lyle Ingredients Americas LLC
Responsible party
Berdine Martin (Research Scientist, Nutrition Science, Purdue University) — Principal investigator
First posted
Aug 8, 2012
Start date
Jun 1, 2012
Primary completion
Apr 30, 2014
Completion
Apr 30, 2014
Last update
May 4, 2018

Study contacts

Connie M Weaver, Ph.D.
principal investigator · Purdue University
Berdine R Martin, PhD
study director · Purdue University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion